Literature DB >> 2228164

Esophageal mucosal resistance. A factor in esophagitis.

J L Goldstein1, P K Schlesinger, H L Mozwecz, T J Layden.   

Abstract

The development of esophageal damage depends on a number of factors. The components in the refluxate, including H+ ion, pepsin, bile salts, and pancreatic enzymes, are able to permeate the mucosa and cause injury. These agents may act individually or in combination. Balancing the effects of these damaging agents is the "esophageal mucosal barrier." This barrier is an integrated complex of anatomic and physiologic components that acts to maintain the integrity of the mucosa. Although the relative efficacy of the various components in developing an effective barrier is not understood completely, their physiologic and clinical importance in the face of "noxious" luminal contents remains critical. Understanding the interplay between the injurious agents in the refluxate and the esophageal mucosal barrier may allow for the development of new therapeutic measures in the treatment and prevention of gastroesophageal reflux disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2228164

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  10 in total

Review 1.  Iatrogenic esophagitis.

Authors:  A S Arora; J A Murray
Journal:  Curr Gastroenterol Rep       Date:  2000-06

2.  Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity.

Authors:  D Nehra; P Howell; C P Williams; J K Pye; J Beynon
Journal:  Gut       Date:  1999-05       Impact factor: 23.059

Review 3.  Inflammatory mediators in the oesophagus.

Authors:  G P Morgan; J G Williams
Journal:  Gut       Date:  1994-03       Impact factor: 23.059

Review 4.  What has the surgeon to know about pathophysiology of reflux disease?

Authors:  B Sivri; R W McCallum
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

5.  Duodenogastric reflux causes growth stimulation of foregut mucosa potentiated by gastric acid blockade.

Authors:  G J Wetscher; R A Hinder; D Kretchmar; R Stinson; G Perdikis; T Smyrk; P J Klingler; T E Adrian
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

6.  Multivariate analysis of pathophysiological factors in reflux oesophagitis.

Authors:  G Cadiot; A Bruhat; D Rigaud; T Coste; A Vuagnat; Y Benyedder; T Vallot; D Le Guludec; M Mignon
Journal:  Gut       Date:  1997-02       Impact factor: 23.059

7.  Effect of growth factors and prostaglandin E2 on restitution and proliferation of rabbit esophageal epithelial cells.

Authors:  P Jimenez; A Lanas; E Piazuelo; F Esteva
Journal:  Dig Dis Sci       Date:  1998-10       Impact factor: 3.199

8.  Biliary tumorigenic effect on hypopharyngeal cells is significantly enhanced by pH reduction.

Authors:  Sotirios G Doukas; Bruno Cardoso; Jacob I Tower; Dimitra P Vageli; Clarence T Sasaki
Journal:  Cancer Med       Date:  2019-06-07       Impact factor: 4.452

Review 9.  Bile reflux and hypopharyngeal cancer (Review).

Authors:  Dimitra P Vageli; Sotirios G Doukas; Panagiotis G Doukas; Benjamin L Judson
Journal:  Oncol Rep       Date:  2021-09-24       Impact factor: 3.906

10.  Proton pump inhibitor-responsive chronic cough without acid reflux: a case report.

Authors:  Kouichi Nobata; Hidetsugu Asanoi
Journal:  J Med Case Rep       Date:  2007-08-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.